1890 results
 End Stage Liver Disease (Cirrhosis) - Complications 
 • Ascites
 • Esophageal Varices
 • Hepatic
Hepatocellular Carcinoma (HCC ... Hepatopulmonary Syndrome ... • Hepatorenal Syndrom ... management #summary #hepatology
Hepatocellular Carcinoma (HCC) Surveillance and Management

#HCC #Hepatocellular #Carcinoma #Surveillance #Management #Treatment #Hepatology
Hepatocellular Carcinoma (HCC ... Management #HCC ... Management #Treatment #Hepatology
Aplastic Anemia and Bone Marrow Failure Syndromes with Pancytopenia

Fanconi Anemia
Acquired Aplastic Anemia
Dyskeratosis Congenita & Telemore Biology
Marrow Failure Syndromes ... Shwachman-Diamond Syndrome ... #Pancytopenia #Syndromes ... anemia #diagnosis #Hematology
Elevated Transaminases / Transaminitis - Differential Diagnosis

 • Infectious: HAV, HCV, HEV, EBV, HSV, CMV
 •
Infectious: HAV, HCV ... Vascular: Budd-chiari syndrome ... Sinusoidal obstruction syndrome ... Diagnosis #causes #hepatology
Glecaprevir and Pibrentasvir in Patients with HCV and Severe Renal Impairment #EBM #Hepatology #HCV #CKD #Glecaprevir
Patients with HCV ... Impairment #EBM #Hepatology ... #HCV #CKD #Glecaprevir
Here is a quick guide on the common direct-acting antivirals (DAAs) for chronic hepatitis C virus
hepatitis C virus (HCV ... table #treatment #hcv ... infectiousdisease #hepatology
Calculating a Reticulocyte Index (RI)
Reticulocyte Index = Absolute Reticulocyte Count / Maturation Correction
Absolute Reticulocyte Count =
reticulocytes x Patient's Hct ... / Normal Hct ... Index #RI #RPI #hematology
Hepatic Masses on CT - Differential Diagnosis by CT Findings

Masses: Hemangioma, Adenoma, FNH, HCC, Fibrolamellar HCC,
Adenoma, FNH, HCC ... Fibrolamellar HCC ... diagnosis #liver #hepatology
Dysplasia in Myelodysplastic Syndrome 
 - 
Dysgranulopoiesis 
 - Dyserythropoiesis 
 - Dysmegakaryopoiesis 

#Dysplasias #MDS #Myelodysplastic
Myelodysplastic Syndrome ... Myelodysplastic #Syndrome ... #Pathology #Hematology
NAFLD / NASH Progression Timeline
Healthy Liver → NAFLD/NASH → 0.25-3.2%/year → Cirrhotic NASH → 0.3-2.6%/year →
0.3-2.6%/year → HCC ... Cirrhotic NASH → HCC ... Progression #Timeline #hepatology